The Latest Cardiac and Vascular News
PARIS–(BUSINESS WIRE)–Regulatory News: “This agreement in principle with the EIB on new repayment terms for the loan is a positive signal for the Company. ” Post this CARMAT (FR0010907956, ALCAR, eligible for PEA-PME equity saving plans), designer and developer of the world’s most advanced total artificial heart, aiming to provide […]
Caesarea, Israel – January 9, 2024 – Arineta Cardio Imaging, a leader in advancing cardiovascular imaging solutions through cutting-edge technology, welcomes its new CEO Doug Ryan to its international team. Ryan brings 30 years of experience creating business infrastructure and crafting market strategies for medical device companies to his role […]
IRVINE, Calif.–(BUSINESS WIRE)– Endologix Inc. LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, is pleased to announce that Scott Ward has been appointed to the Endologix Board of Directors. Scott Ward was most recently the CEO and Chairman of the […]
SAN FRANCISCO, CA – JANUARY 8, 2024 – Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced that the company has surpassed adoption in 1,500 hospitals in the United States, including the majority of the 50 largest healthcare systems. The company’s user base grew in 2023 by […]
2023 reported preliminary unaudited revenue in the range of approximately $1.255 billion – $1.259 billion, up approximately 9.0% – 9.4% year-over-year 2023 preliminary unaudited constant currency revenue* in the range of up approximately 9.6% – 9.9% year over year 2023 financial results and 2024 guidance to be released February 28, […]
ALISO VIEJO, Calif., Jan. 8, 2024 /PRNewswire/ — Okami Medical Inc., a medical device company focused on developing innovative solutions that address key unmet clinical needs in peripheral vascular intervention, today announced the appointment of Rhonda Robb as President and Chief…
CHARLESTOWN, Mass., Jan. 08, 2024 (GLOBE NEWSWIRE) — Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced that it has entered into a securities purchase agreement with a select group of institutional accredited investors for an approximately $108.9 million […]
LATHAM, N.Y.–(BUSINESS WIRE)–AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients, today announced financial results for the second quarter of fiscal year 2024, which ended November 30, 2023. “Today, we are announcing meaningful steps in our strategic transformation. We have initiated a restructuring of our
SOUTH JORDAN, Utah, Jan. 03, 2024 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that Merit Chairman and CEO, Fred Lampropoulos, is scheduled to present at the J.P. Morgan 42nd Annual Healthcare Conference on January 8, 2024, at […]
HUNTINGTON BEACH, Calif. & HOUSTON & GOLD COAST, Australia–(BUSINESS WIRE)–BiVACOR, Inc., a clinical-stage medical technology company developing a total artificial heart (TAH), today announced that Jim Dillon has been named chief executive officer and a member of its board of directors. “We are thrilled to have him join as CEO.” […]
